Literature DB >> 17617856

Homeostatic expansion permits T cells to re-enter the thymus and deliver antigen in a tolerogenic fashion.

C Tian1, J Bagley, J Iacomini.   

Abstract

We previously have shown that delivery of alloantigen on T cells can be used to induce tolerance through central deletion. Here, we analyzed the requirements for tolerance induced by T cells. Adoptively transferred allogeneic T cells undergo extensive homeostatic proliferation in the periphery of lethally irradiated hosts receiving a syngeneic bone marrow transplant, and acquire a memory-like cell surface phenotype. Analysis of the kinetics of thymic re-entry of transferred T cells revealed that T cells undergo homeostatic proliferation in the periphery prior to re-entry into the thymus. Prevention of homeostatic proliferation results in a failure of transferred T cells to re-enter the thymus. In the absence of homeostatic proliferation, adoptively transferred T cells were unable to induce tolerance. These date suggest that homeostatic proliferation of T cells resulting in an activated cell surface phenotype is required for thymic re-entry and is mechanistically linked to the ability of T cells to induce tolerance.

Mesh:

Substances:

Year:  2007        PMID: 17617856     DOI: 10.1111/j.1600-6143.2007.01891.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  6 in total

1.  Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.

Authors:  Chaorui Tian; Xueli Yuan; Peter T Jindra; Jessamyn Bagley; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2010-05-08       Impact factor: 3.969

2.  Derivation and maintenance of virtual memory CD8 T cells.

Authors:  Adovi D Akue; June-Yong Lee; Stephen C Jameson
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

3.  Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.

Authors:  Chaorui Tian; Xueli Yuan; Jessamyn Bagley; Bruce R Blazar; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2008-02-15       Impact factor: 3.969

4.  Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primates.

Authors:  Aurélie Moreau; Rita Vicente; Laurence Dubreil; Oumeya Adjali; Guillaume Podevin; Chantal Jacquet; Jack Yves Deschamps; David Klatzmann; Yan Cherel; Naomi Taylor; Philippe Moullier; Valérie S Zimmermann
Journal:  Mol Ther       Date:  2008-12-16       Impact factor: 11.454

Review 5.  Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.

Authors:  J García-Castro; C Trigueros; J Madrenas; J A Pérez-Simón; R Rodriguez; P Menendez
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

6.  Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.

Authors:  P T Jindra; S Tripathi; C Tian; J Iacomini; J Bagley
Journal:  Gene Ther       Date:  2012-07-26       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.